None listed
Conditions
Interventions
Intervention1: Milk cobalamin: We supplemented B12 deficient pregnant women with high oral dose (5 mg/d) of HO-B12/CN B12/placebo at early stage for 2 weeks and then continued with 2 x200 mL of milk d
Sponsors
Aarhus University Denmark
Eligibility
Inclusion criteria
Inclusion criteria: Confirmed pregnant women with plasma B12 less than 200 pg/ml
Exclusion criteria
Exclusion criteria: Non vegetarians, cancer and the participants consuming vitamin B12 pills and the drugs known to influence vitamin B12 absorption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Beneficial effect of Vitamin B12 supplementation on breast milk and off-springsTimepoint: Early pregnancy to 4 months postpartum | — |
Secondary
| Measure | Time frame |
|---|---|
| Normal birth weight children and healthy cardiometabolic statusTimepoint: Early pregnancy to 4 months postpartum | — |
Countries
India
Contacts
Public ContactDr Sadanand S Naik
Pathology Department Deenanath Mangeshkar Hospital and Research Center
Outcome results
None listed